Your browser doesn't support javascript.
loading
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance status.
Alessi, Joao V; Ricciuti, Biagio; Jiménez-Aguilar, Elizabeth; Hong, Fangxin; Wei, Zihan; Nishino, Mizuki; Plodkowski, Andrew J; Sawan, Peter; Luo, Jia; Rizvi, Hira; Carter, Brett W; Heymach, John V; Altan, Mehmet; Hellmann, Matthew; Awad, Mark.
Afiliação
  • Alessi JV; Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Ricciuti B; Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Jiménez-Aguilar E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Comunidad de Madrid, Spain.
  • Hong F; Department of Data Sciences, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Wei Z; Department of Data Sciences, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Nishino M; Department of Radiology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Sawan P; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Luo J; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Carter BW; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Altan M; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hellmann M; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Awad M; Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA mark_awad@dfci.harvard.edu.
J Immunother Cancer ; 8(2)2020 08.
Article em En | MEDLINE | ID: mdl-32753547
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Imunoterapia / Neoplasias Pulmonares Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Imunoterapia / Neoplasias Pulmonares Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article